Antibodies under a microscope

HV212056

Research Grade Blisibimod

Description

The antibody is a Human Fusion - [peptide 16-mer - peptide 19-mer]2 - IGHG1 Fc (Fragment constant) targets Human CD257/BAFF/BLYS

Target

CD257/BAFF/BLYS

Target Alias Names

BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor

Isotype/Mimetic

Fusion - [peptide 16-mer - peptide 19-mer]2 - IGHG1 Fc (Fragment constant)

Animal-Derived Biomaterials Used

No

Sequence Available

No

Original Discovery Method

Unknown

Antibody/Binder Origins

Animal-free discovery, In vitro recombinant expression